RANK pathway inhibition sensitizes triple-negative breast cancer to CDK4/6 inhibitors and enhances immune response
Gomes, I., Martelo, M., Vilela, R. D., Jimenez, M., Trinidad, E. M., Gómez-Miragaya, J., González-Suárez, E., Martins, É., Torres, S. S., Corredeira, P., Miranda, J. L., [...]